Last CNY34.35 CNY
Change Today 0.00 / 0.00%
Volume 0.0
600211 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 10/10/14 All times are local (Market data is delayed by at least 15 minutes).

tibet rhodiola pharm-a (600211) Snapshot

Open
CNY33.90
Previous Close
CNY34.35
Day High
CNY34.35
Day Low
CNY33.16
52 Week High
10/10/14 - CNY34.35
52 Week Low
12/27/13 - CNY16.45
Market Cap
5.0B
Average Volume 10 Days
591.3K
EPS TTM
CNY0.26
Shares Outstanding
145.6M
EX-Date
06/27/14
P/E TM
130.6x
Dividend
CNY0.06
Dividend Yield
0.17%
Current Stock Chart for TIBET RHODIOLA PHARM-A (600211)

Related News

No related news articles were found.

tibet rhodiola pharm-a (600211) Related Businessweek News

No Related Businessweek News Found

tibet rhodiola pharm-a (600211) Details

Tibet Rhodiola Pharmaceutical Holding Company is engaged in the production and distribution of pharmaceuticals in China. The company wholesales pharmaceuticals, as well as distributes proprietary drug products. It has operations primarily in southwest China, Beijing, Shanghai, Guangdong province, and other regions. The company was founded in 1999 and is based in Lhasa, China.

Founded in 1999

tibet rhodiola pharm-a (600211) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tibet rhodiola pharm-a (600211) Key Developments

Tibet Rhodiola Pharmaceutical Holding Company Elects Lu Xianpei as Independent Director

Tibet Rhodiola Pharmaceutical Holding Company at its Special Shareholders' Meeting held on September 30, 2014, approved the proposal of electing Lu Xianpei Independent Director of fifth Directorate.

Tibet Rhodiola Pharmaceutical Holding Company Announces Executive Appointments

Tibet Rhodiola Pharmaceutical Holding Company approved the appointment of Chen Xi as Executive Deputy General Manager, and Zeng Zhaohui as Deputy General Manager.

Tibet Rhodiola Pharmaceutical Holding Company, Board Meeting, Sep 17, 2014

Tibet Rhodiola Pharmaceutical Holding Company, Board Meeting, Sep 17, 2014. Agenda: To discuss and approve issues including the proposal of appointing Chen Xi Executive Deputy General Manager; to approve the proposal of appointing Zeng Zhaohui Deputy General Manager; and to approve the proposal of adjusting standards for remuneration of senior management.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600211:CH CNY34.35 CNY 0.00

600211 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600211.
View Industry Companies
 

Industry Analysis

600211

Industry Average

Valuation 600211 Industry Range
Price/Earnings 100.0x
Price/Sales 3.3x
Price/Book 12.7x
Price/Cash Flow 134.3x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET RHODIOLA PHARM-A, please visit www.xzyy.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.